SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026998
Filing Date
2021-05-12
Accepted
2021-05-12 16:12:08
Documents
82
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kdny-10q_20210331.htm   iXBRL 10-Q 2796672
2 EX-31.1 kdny-ex311_10.htm EX-31.1 21122
3 EX-31.2 kdny-ex312_7.htm EX-31.2 21413
4 EX-32.1 kdny-ex321_6.htm EX-32.1 8132
  Complete submission text file 0001564590-21-026998.txt   10583547

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA kdny-20210331.xsd EX-101.SCH 68703
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kdny-20210331_cal.xml EX-101.CAL 63826
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kdny-20210331_def.xml EX-101.DEF 194849
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20210331_lab.xml EX-101.LAB 504572
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20210331_pre.xml EX-101.PRE 392029
10 EXTRACTED XBRL INSTANCE DOCUMENT kdny-10q_20210331_htm.xml XML 2233574
Mailing Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102
Business Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37345 | Film No.: 21915202
SIC: 2834 Pharmaceutical Preparations